此外,2023 V1版前列腺癌NCCN在风险分层原则、影像学原则、主动监测和观察原则、放疗原则、手术原则、雄激素剥夺治疗原则和非激素系统治疗原则均有更新,详见指南原文,也可留言告诉小编您感兴趣的内容,以便我们后续整理编译。 参考文献: NCCN Clinical Practice Guidelines in Oncology:Prostate Cancer(Version 1.2023). 编辑...
NCCNGuidelinesVersion4.2023 Comprehensive IatieafCantents Cancer NCCNProstateCancerDmsunnion Network SYSTEMICTHERAPYFORCASTRATION-SENSITIVEPROSTATECANCER Monitortingtpreferred)| Mo*s,or ADruuu|See |Studies Systemis |Physicalexam+nogatlve Therapyfot
新版NCCN指南将未经去势治疗前列腺癌(castration-naive prostate cancer)调整为去势敏感性前列腺癌(castration-sensitive prostate cancer,CSPC),更加精准地定义治疗人群。 同时,基于ARASENS和PEACE-1研究,CSPC的系统治疗不再推荐以多西他赛为基础联合ADT的二联方案,修改为在多西他赛耐受患者中推荐ADT+多西他赛基础上联合新型内...
Oncology (NCCN Guidelines®) for Lung Cancer Screening Version 2.2023 – May 17, 2023. View the NCCN Guidelines Find an NCCN Cancer for Patients free online Center near you NCCN.org/patientguidelines NCCN.org/cancercenters Connect with us NCCN Guidelines for Patients® Lung Cancer Screening, ...
sDiseaseKidneyCancerMelanomaMyelodysplasticSyndromesMultipleMyelomaNeuroendocrineTumorsNon-Hodgkin’sLymphomaNon-MelanomaSkinCancersNon-SmallCellLungCancerOccultPrimaryAdultCancerPainPediatricCancerPainOvarianCancerPancreaticAdenocarcinomaProstateCancerSmallCellLungCancerSoftTissueSarcomaTesticularCancerThyroidCarcinomaUterineCancers…....
美国国立综合癌症网络(National Comprehensive Cancer Network,NCCN)每年更新《肿瘤临床实践指南—肺癌筛查》,2024年第2版已于2023年10月发布。2024版指南在 2023版的基础上对肺癌筛查的肺癌风险因素及评估、初次用后续筛查发现肺部病灶类型及随访策略、...
Risk stratification to guide molecular testing and treatment is emphasized in the latest prostate cancer guidelines from the NCCN. Recommendations for germline testing, molecular testing, and initial therapy have been developed for each risk category, each of which has its own ...
announced today that The National Comprehensive Cancer Network® (NCCN) Breast Cancer Panel included both goserelin 3.6 mg every 4 weeks and goserelin 10.8 mg every 12 weeks, as methods for ovarian function suppression in Version 1.2024 of the Breast Guideli...
In March, the National Comprehensive Cancer Network (NCCN) updated its “Antiemesis Guidelines,” releasing Version 2.2010. In addition to updating the “Discussion” section, the NCCN changed the structure for preventing emesis in patients receiving chemotherapy with a moderate emetic risk, separating ...
NCCN Guidelinesand this illustration may not be reproduced in any form without the express written permission of NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?) Rectal Cancer Version 1.2021 — December 22, 2020 NCCN.org NCCN Guidelines for Patients? available at /patients ...